Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.coph.2020.11.002 http://scihub22266oqcxt.onion/10.1016/j.coph.2020.11.002 33341460!7746087!33341460     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\33341460.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Curr+Opin+Pharmacol 2021 ; 56 (ä): 85-92 Nephropedia Template TP {{tp|p=33341460|t=2021. Nanotechnology in pulmonary medicine |pdf=|usr=}}{{33341460}} gab.com Text Nanotechnology in pulmonary medicine JO: Curr Opin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33341460 #FOAvip Nanotechnology in medicine-nanomedicine-is extensively employed to diagnose, treat, and prevent pulmonary diseases. Over the last few years, this brave new world has made remarkable progress, offering opportunities to address historical clinical challenges in pulmonary diseases including multidrug resistance, adverse side effects of conventional therapeutic agents, novel imaging, and earlier disease detection. Nanomedicine is also being applied to tackle the new emerging infectious diseases, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), influenza A virus subtype H1N1 (A/H1N1), and more recently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this review we provide both a historical overview of the application of nanomedicine to respiratory diseases and more recent cutting-edge approaches such as nanoparticle-mediated combination therapies, novel double-targeted nondrug delivery system for targeting, stimuli-responsive nanoparticles, and theranostic imaging in the diagnosis and treatment of pulmonary diseases. Twit Text FOAVip Nanotechnology in pulmonary medicine ????Curr Opin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33341460 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33341460 #FOAvip English Wikipedia <ref>{{Cite pmid|33341460}}</ref> Nanotechnology in pulmonary medicine #MMPMID33341460 Doroudian M; O' Neill A; Mac Loughlin R; Prina-Mello A; Volkov Y; Donnelly SC Curr Opin Pharmacol 2021[Feb]; 56 (ä): 85-92 PMID33341460show ga Nanotechnology in medicine-nanomedicine-is extensively employed to diagnose, treat, and prevent pulmonary diseases. Over the last few years, this brave new world has made remarkable progress, offering opportunities to address historical clinical challenges in pulmonary diseases including multidrug resistance, adverse side effects of conventional therapeutic agents, novel imaging, and earlier disease detection. Nanomedicine is also being applied to tackle the new emerging infectious diseases, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), influenza A virus subtype H1N1 (A/H1N1), and more recently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this review we provide both a historical overview of the application of nanomedicine to respiratory diseases and more recent cutting-edge approaches such as nanoparticle-mediated combination therapies, novel double-targeted nondrug delivery system for targeting, stimuli-responsive nanoparticles, and theranostic imaging in the diagnosis and treatment of pulmonary diseases. |Animals[MESH] |Coronavirus Infections/drug therapy[MESH] |Drug Carriers[MESH] |Drug Resistance/physiology[MESH] |Humans[MESH] |Nanotechnology/*methods[MESH] |Pulmonary Medicine/*methods[MESH]Nanotechnology in pulmonary medicine (epmc).pdf DeepDyve Pubget Overpricing